New Rochelle, NY, February 11, 2014-An innovative therapeutic strategy for reducing the levels of toxic protein fragments associated with Huntington's disease uses a new approach called exon skipping to remove the disease-causing component of the essential protein, huntingtin.
via New Rochelle Newswire http://ift.tt/NyJw0d
via New Rochelle Newswire http://ift.tt/NyJw0d
No comments:
Post a Comment